Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerry M Collins

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 14, 2013
First-in-human phase 0 trial of oral 5-iodo-2-pyrimidinone-2'-deoxyribose in patients with advanced malignanciesShivaani Kummar, Larry Anderson, Kimberly Hill, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 2, 2005
A simplified analysis of [18F]3'-deoxy-3'-fluorothymidine metabolism and retentionAnthony F Shields, David A Briston, Samatha Chandupatla, et al.
Cancer Research|April 28, 2017
The National Cancer Institute ALMANAC: A Comprehensive Screening Resource for the Detection of Anticancer Drug Pairs with Enhanced Therapeutic ActivitySusan L Holbeck, Richard Camalier, James A Crowell, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2018
Erythrofordins D and E, two new cassaine-type diterpenes from Erythrophleum suaveolensTanja Grkovic, Jason R Evans, Rhone K Akee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2004
Distribution of 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl) uracil in mice bearing colorectal cancer xenografts: rationale for therapeutic use and as a positron emission tomography probe for thymidylate synthaseJulie L Eiseman, Clive Brown-Proctor, Paul E Kinahan, et al.
Molecular Cancer Therapeutics|April 3, 2021
F-aza-T-dCyd (NSC801845), a Novel Cytidine Analog, in Comparative Cell Culture and Xenograft Studies with the Clinical Candidates T-dCyd, F-T-dCyd, and Aza-T-dCydJoel Morris, Donn G Wishka, Omar D Lopez, et al.
Molecular Cancer Therapeutics|December 19, 2019
Targeting Protein Translation by Rocaglamide and Didesmethylrocaglamide to Treat MPNST and Other SarcomasLong-Sheng Chang, Janet L Oblinger, Sarah S Burns, et al.
Neuro-Oncology|February 11, 2004
Review of microdialysis in brain tumors, from concept to application: first annual Carolyn Frye-Halloran symposiumRamsis K Benjamin, Fred H Hochberg, Elizabeth Fox, et al.
Molecular Cancer Therapeutics|August 7, 2023
Targeted Investigational Oncology Agents in the NCI-60: A Phenotypic Systems-based ResourceJoel Morris, Mark W Kunkel, Stephen L White, et al.
Oncotarget|November 20, 2020
Phase I trial of TRC102 (methoxyamine HCl) in combination with temozolomide in patients with relapsed solid tumors and lymphomasGeraldine O'Sullivan Coyne, Shivaani Kummar, Robert S Meehan, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 14, 2013
First-in-human phase 0 trial of oral 5-iodo-2-pyrimidinone-2'-deoxyribose in patients with advanced malignanciesShivaani Kummar, Larry Anderson, Kimberly Hill, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 2, 2005
A simplified analysis of [18F]3'-deoxy-3'-fluorothymidine metabolism and retentionAnthony F Shields, David A Briston, Samatha Chandupatla, et al.
Cancer Research|April 28, 2017
The National Cancer Institute ALMANAC: A Comprehensive Screening Resource for the Detection of Anticancer Drug Pairs with Enhanced Therapeutic ActivitySusan L Holbeck, Richard Camalier, James A Crowell, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2018
Erythrofordins D and E, two new cassaine-type diterpenes from Erythrophleum suaveolensTanja Grkovic, Jason R Evans, Rhone K Akee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2004
Distribution of 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl) uracil in mice bearing colorectal cancer xenografts: rationale for therapeutic use and as a positron emission tomography probe for thymidylate synthaseJulie L Eiseman, Clive Brown-Proctor, Paul E Kinahan, et al.
Molecular Cancer Therapeutics|April 3, 2021
F-aza-T-dCyd (NSC801845), a Novel Cytidine Analog, in Comparative Cell Culture and Xenograft Studies with the Clinical Candidates T-dCyd, F-T-dCyd, and Aza-T-dCydJoel Morris, Donn G Wishka, Omar D Lopez, et al.
Molecular Cancer Therapeutics|December 19, 2019
Targeting Protein Translation by Rocaglamide and Didesmethylrocaglamide to Treat MPNST and Other SarcomasLong-Sheng Chang, Janet L Oblinger, Sarah S Burns, et al.
Neuro-Oncology|February 11, 2004
Review of microdialysis in brain tumors, from concept to application: first annual Carolyn Frye-Halloran symposiumRamsis K Benjamin, Fred H Hochberg, Elizabeth Fox, et al.
Molecular Cancer Therapeutics|August 7, 2023
Targeted Investigational Oncology Agents in the NCI-60: A Phenotypic Systems-based ResourceJoel Morris, Mark W Kunkel, Stephen L White, et al.
Oncotarget|November 20, 2020
Phase I trial of TRC102 (methoxyamine HCl) in combination with temozolomide in patients with relapsed solid tumors and lymphomasGeraldine O'Sullivan Coyne, Shivaani Kummar, Robert S Meehan, et al.
Pageof 4